<DOC>
	<DOCNO>NCT02140528</DOCNO>
	<brief_summary>This study case-control prospective , clinal trial ass safety efficacy allogeneic adipose derive mesenchymal stem cell transplantation heal recent tibial fracture 40 patient .</brief_summary>
	<brief_title>Allogeneic Mesenchymal Stem Cell Transplantation Tibial Closed Diaphyseal Fractures</brief_title>
	<detailed_description>In study eligible patient divide 2 group.20 patient receive allogeneic adipose derive mesenchymal stem cell fracture site ( case group ) patient receive placebo fracture site ( control group ) . To assess outcome , evaluate patient 2 , 6 week 3 , 6 month transplantation : X-ray , BMD , VAS biochemical analysis laboratory test .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Tibial Fractures</mesh_term>
	<criteria>Age 18 65 year The presence tibial fracture base X ray tibial fracture limit diaphysial Addiction Pregnancy liver kidney disease uncontrolled diabetes heart lung disease immune deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Allogenic adipose derive mesenchymal stem cell tibial fracture</keyword>
</DOC>